Trial Profile
A long term follow up of relapsing remitting multiple sclerosis patients who have been treated with intereron beta -1b (Betaferon) at least 5 years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jun 2011
Price :
$35
*
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Schering Oy
- 04 Jun 2011 New trial record